InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+43.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Tak Paul Peter, Chief Executive Officer. Officer active across 1 company, notably Candel Therapeutics, Inc.. Cumulatively, 13 reports have been published. Breakdown: 3 buys · 6 sells. Total volume traded: €1.3m. Activity tracked since 29 July 2021. The latest transaction was filed on 18 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
25,772 shares@ US$8.770115.0% of flowCommon StockSEC:0000950170-25-042725:0
21,704 shares@ US$7.22511.0% of flowCommon StockSEC:0000950170-25-006724:0
21,172 shares@ US$8.218212.2% of flowCommon StockSEC:0000950170-25-004198:0
48,847 shares@ US$4.555615.3% of flowCommon StockSEC:0000950170-24-132930:0
12,900 shares@ US$1.551.4% of flowCommon StockSEC:0000950170-24-129677:0
22,528 shares@ US$6.47269.7% of flowCommon StockSEC:0000950170-24-084761:0
20,293 shares@ US$5.97348.1% of flowCommon StockSEC:0000950170-24-083401:0
43,443 shares@ US$0.902.6% of flowCommon StockSEC:0001209191-23-056987:0
180,108 shares0Common StockSEC:0001209191-23-056801:0
3,050 shares@ US$1.700.4% of flowCommon StockSEC:0001209191-22-060689:0
Ideal exit: 4 Sept 2023 (T+270)
195,906 shares0Common StockSEC:0000899243-22-037231:0
25,000 shares@ US$8.0012.2% of flowCommon StockSEC:0000899243-21-031097
Ideal exit: 25 Apr 2022 (T+270)
25,000 shares@ US$8.000.054% mcap50.0% of flowCommon StockSEC:0000899243-21-031097:0
Ideal exit: 25 Apr 2022 (T+270)
13 of 13 declarations
About Tak Paul Peter
Paul Peter Tak is the Chief Executive Officer at Candel Therapeutics, Inc. He is responsible for the overall direction of the company, overseeing operations and growth strategies. His role is essential for the success and performance of the business.
